Transfusion support in hematopoietic stem cell transplantation
Blood Research
;
: 1-7, 2023.
Article
in English
| WPRIM
| ID: wpr-999719
ABSTRACT
Transfusion support for hematopoietic stem cell transplantation (HSCT) is an essential part of supportive care, and compatible blood should be transfused into recipients. As leukocyte antigen (HLA) matching is considered first and as the blood group does not impede HSCT, major, minor, bidirectional, and RhD incompatibilities occur that might hinder transfusion and cause adverse events. Leukocyte reduction in blood products is frequently used, and irradiation should be performed for blood products, except for plasma. To mitigate incompatibility and adverse events, local transfusion guidelines, hospital transfusion committees, and patient management should be considered.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Blood Research
Year:
2023
Type:
Article
Similar
MEDLINE
...
LILACS
LIS